In a recent study published in the journal The Lancet Digital Health, scientists in the United States evaluated the efficacy and challenges of artificial intelligence (AI) in clinical practice by ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

In two phase 3, double-blind, placebo-controlled trials, the Janus kinase inhibitor ruxolitinib showed superiority to vehicle control in facial repigmentation of vitiligo.

A digital pathology AI model to predict immune-oncology biomarker status and pembrolizumab response in a real-world cohort of patients with colorectal and breast cancer. Changes in non-small cell lung ...

Objectives To evaluate the efficacy of a new multicomponent, exercise-based injury prevention programme in football players 13–19 years old. Methods Two-arm cluster-randomised controlled trial with ...